Skip to main content

Table 3 3-year overall, disease-free, locoregional failure-free, and distant metastasis-control rates in T4a patients

From: Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer center

 

3-year OS

3-year DFS

3-year LRC

3-year DMC

T4a Definitive

71 (42–100)

40 (11–69)

50 (21–79)

48 (15–81)

T4a Adjuvant

75 (50–100)

56 (25–87)

56 (25–87)

75 (50–100)

P-value

0.390

0.306

0.384

0.180